Tender Details

Country: Belarus
Summary: 24/08-4 Immunosuppressant (adalimumab)
BYT Ref No: 97059467
Deadline: 03 Mar 2024
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: BYN 374231027
Notice Type: Tender
Document Ref. No.: AU20240216297368
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
24/08-4 Immunodeperessant (Adalimumab)
Industry: pharmacology drugs
Documents:

Tender Notice

Dogovor_k_auktzionnym__dokumentam_SOS_2024_rezidenty__proizvoditeli.doc

Dogovor_k_auktzionnym__dokumentam_SOS_2024_rezidenty_posredniki.doc

Prilogenie__1.xlsx

Prilogenie__2.xlsx

Prilogenie__5_lyubaya_valyuta.xlsx

TZ_Adalimumab.pdf

TZ_Adalimumab_det1.pdf

24_08_41.doc

Kontrakt_k_auktzionnym__dokumentam_SOS_2024_nerezidenty.doc

au_purchase_297368.xls

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

24/08-4 Immunosuppressant (adalimumab) - Belarus Tender

The TRADE AND PRODUCTION REPUBLICAN UNITARY ENTERPRISE "BELFARMACIA", a Government sector organization in Belarus, has announced a new tender for 24/08-4 Immunosuppressant (adalimumab). This tender is published on BelarusTenders under BYT Ref No: 97059467 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-03-03.

The estimated tender value is BYN 374231027, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.